The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...

If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

Note :Financial Information is based on consolidated numbers.